JAMA Oncology
Original Investigation
December 21, 2023
Sanne-Marije J. A.听Hazen,听MD; Tania C.听Sluckin,听MD; Martijn P. W.听Intven,听MD, PhD; Geerard L.听Beets,听MD, PhD; Regina G. H.听Beets-Tan,听MD, PhD; Wernard A. A.听Borstlap,听MD, PhD; Tineke E.听Buffart,听MD, PhD; Jeroen听Buijsen,听MD, PhD; Jacobus W. A.听Burger,听MD, PhD; Susan听van Dieren,听PhD; Edgar J. B.听Furn茅e,听MD, PhD; E. Debby听Geijsen,听MD; Roel听Hompes,听MD, PhD; Karin听Horsthuis,听MD, PhD; Jeroen W. A.听Leijtens,听MD, PhD; Monique听Maas,听MD, PhD; Jarno听Melenhorst,听MD, PhD; Joost听Nederend,听MD, PhD; Koen C. M. J.听Peeters,听MD, PhD; Tom听Rozema,听MD; Jurriaan B.听Tuynman,听MD, PhD; Cornelis听Verhoef,听MD, PhD; Marianne听de Vries,听MD, PhD; Henderik L.听van Westreenen,听MD, PhD; Johannes H.W.听de Wilt,听MD, PhD; David D. E.听Zimmerman,听MD, PhD; Corrie A. M.听Marijnen,听MD, PhD; Pieter J.听Tanis,听MD, PhD; Miranda听Kusters,听MD, PhD; Dutch Snapshot Research Group
JAMA Oncol. 2023; 10(2):202-211. 10.1001/jamaoncol.2023.5444
This cross-sectional study examines the association of decreased use of neoadjuvant radiotherapy with cancer-related outcomes and overall survival.
JAMA Otolaryngology鈥揌ead & Neck Surgery
Original Investigation
November 23, 2022
Sam P. J.听van Dijk,听BSc; Hannelore I.听Coerts,听BSc; Ivona听Lon膷ar,听BSc; Cornelis听Verhoef,听MD, PhD; Schelto听Kruijff,听MD, PhD; Anton F.听Engelsman,听MD, PhD; Robin P.听Peeters,听MD, PhD; Tessa M.听van Ginhoven,听MD, PhD
free access
JAMA Otolaryngol Head Neck Surg. 2022; 149(1):42-48. 10.1001/jamaoto.2022.3686
This national cohort study assesses the occurrence and risk factors of recurrent disease in all Dutch patients with papillary thyroid microcarcinoma who received surgical treatment according to the Dutch guideline between January 2000 and December 2020.
JAMA Otolaryngology鈥揌ead & Neck Surgery
Original Investigation
February 10, 2022
Sam P. J.听van Dijk,听BSc; Hannelore I.听Coerts,听BSc; Sabrina T. G.听Gunput,听PhD; Evert F. S.听van Velsen,听MD, MSc; Marco听Medici,听MD, PhD; Adriaan听Moelker,听MD, PhD; Robin P.听Peeters,听MD, PhD; Cornelis听Verhoef,听MD, PhD; Tessa M.听van Ginhoven,听MD, PhD
free access
JAMA Otolaryngol Head Neck Surg. 2022; 148(4):317-325. 10.1001/jamaoto.2021.4381
This systematic review and meta-analysis evaluates the effectiveness and safety of radiofrequency ablation for low-risk papillary microcarcinoma of the thyroid.
JAMA Surgery
Original Investigation
January 1, 2019
Rutger C. H.听Stijns,听MD; Eelco J. R.听de Graaf,听MD, PhD; Cornelis J. A.听Punt,听MD, PhD; Iris D.听Nagtegaal,听MD, PhD; Joost J. M. E.听Nuyttens,听MD, PhD; Esther听van Meerten,听MD, PhD; Pieter J.听Tanis,听MD, PhD; Ignace H. J. T.听de Hingh,听MD, PhD; George P.听van der Schelling,听MD, PhD; Yair听Acherman,听MD; Jeroen W. A.听Leijtens,听MD; Andreas J. A.听Bremers,听MD, PhD; Geerard L.听Beets,听MD, PhD; Christiaan听Hoff,听MD, PhD; Cornelis听Verhoef,听MD, PhD; Corrie A. M.听Marijnen,听MD, PhD; Johannes H. W.听de Wilt,听MD, PhD; for the CARTS Study Group
free access
JAMA Surg. 2019; 154(1):47-54. 10.1001/jamasurg.2018.3752
This phase II feasibility study explores the long-term oncological outcomes and health-related quality of life of patients with cT1-3N0M0 rectal cancer who underwent neoadjuvant chemoradiotherapy followed by transanal endoscopic microsurgery.